Minimally Invasive Aortic Valve Replacement in Contemporary Practice: Clinical and Hemodynamic Performance from a Prospective Multicenter Trial.
Bart J J VeldersMichiel D VriesendorpMichael J ReardonVivek RaoRüdiger LangeHimanshu J PatelElizabeth GearhartJoseph F SabikRobert J M KlautzPublished in: The Thoracic and cardiovascular surgeon (2022)
Three-year outcomes after MI-AVR with the Avalus bioprosthetic valve were comparable to conventional AVR. These results provide important insights into the overall ability to reduce the invasiveness of AVR without compromising outcomes.
Keyphrases
- aortic valve replacement
- aortic valve
- aortic stenosis
- transcatheter aortic valve implantation
- minimally invasive
- transcatheter aortic valve replacement
- ejection fraction
- left ventricular
- mitral valve
- primary care
- healthcare
- phase iii
- clinical trial
- study protocol
- phase ii
- type diabetes
- heart failure
- skeletal muscle
- open label
- metabolic syndrome
- double blind
- atrial fibrillation